Pediatric Neurology Device Global Market Report 2024

The pediatric neurology device market size has grown strongly in recent years. It will grow from $2.33 billion in 2023 to $2.5 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth observed during the historical period can be attributed to several factors, including increased awareness and early diagnosis of pediatric neurological disorders, government support for pediatric healthcare initiatives, collaborative efforts in pediatric neurological research, improvements in pediatric healthcare infrastructure, a growing prevalence of pediatric neurological disorders, and the presence of patient advocacy and support groups.

The pediatric neurology device market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The anticipated growth in the forecast period can be attributed to a global emphasis on child health, the integration of personalized medicine approaches, an increasing awareness of early intervention in pediatric neurological disorders, the implementation of global health policies for children, and international collaboration in pediatric healthcare. Major trends expected in the forecast period include advancements in wearable neurological monitoring devices, the integration of artificial intelligence in diagnostic tools, the development of pediatric-specific neuromodulation devices, the expansion of telehealth and remote monitoring solutions, the introduction of child-friendly neuroimaging technologies, and a focus on non-invasive and minimally invasive interventional techniques in pediatric neurology.

The anticipated increase in the prevalence of autism in children is expected to drive the growth of the pediatric neurology devices market. Autism, a developmental condition affecting how individuals perceive and interact with others, presents challenges in communication and social interaction. Pediatric neurology devices play a crucial role in the diagnosis and treatment of children with autism, contributing to improvements in their quality of life, social skills, and management of cognitive and behavioral symptoms. In March 2023, data from the Centers for Disease Control and Prevention (CDC) revealed that, according to the Autism and Developmental Disabilities Monitoring (ADDM) Network, one in 36 (2.8%) 8-year-old children in 11 communities across the United States were identified with autism spectrum disorder (ASD). Consequently, the rising prevalence of autism in children is a key factor driving the growth of the pediatric neurology devices market.

The increasing number of pediatric patients is also expected to propel the growth of the pediatric neurology device market. Pediatric patients, typically individuals under the age of 15 or 21, depending on the country, require specialized medical attention. Pediatric neurology devices are specifically designed to meet the unique needs of infants, children, and adolescents, considering the ongoing development of their bodies and brains. These devices contribute to the diagnosis and treatment of various neurological disorders in children, including but not limited to stroke, seizures, hydrocephalus, and oncology. For instance, as of July 2023, the World Health Organization reported an increase in the proportion of children receiving their first dose of the measles vaccine from 81% in 2021 to 83% in 2022. This increase in pediatric patients is a significant driver behind the growth of the pediatric neurology device market.

The cost of treating neurological diseases is impeding the growth of the pediatric neurology devices market during the forecast period. The high expenses associated with pediatric neurological treatments, encompassing specialized surgeries, medications, and therapies, create a financial barrier for many families. This restricted access to treatment has the potential to cause delays or prevent children from receiving the necessary care, consequently diminishing the demand for associated devices. A study published by Neurology.org in 2023 highlights the annual cost associated with functional neurologic disorders, ranging from $4,964 to $86,722 US dollars, encompassing both direct and substantial indirect costs. As a result, the cost of neurological disease treatment is acting as a hindrance to the growth of the pediatric neurology devices market.

Major companies in the pediatric neurology device market are actively developing new products, such as external trigeminal nerve stimulation devices, with the aim of reaching larger customer bases, increasing sales, and boosting revenue. An external trigeminal nerve stimulation device is a minimally invasive medical treatment utilizing a small electrical device applied to the forehead to administer neuromodulation. For example, in October 2022, NeuroSigma Inc., a US-based medical device company, launched the Monarch external Trigeminal Nerve Stimulation (eTNS) System. This device is designed to treat patients with attention-deficit/hyperactivity disorder (ADHD) aged 7 to 12 who are not receiving medication for the condition. The unique feature of this device involves applying a small patch to the patient's forehead while they sleep, delivering a low-level electrical pulse to the trigeminal nerve. Clinical trial results, based on the clinician-administered ADHD Rating Scale (ADHD-RS) score, demonstrated that treatment with the eTNS device significantly improved ADHD symptoms compared to placebo.

In July 2022, ArchiMed SAS, a France-based investment company specializing in the healthcare sector, acquired Natus Medical Incorporated for $1.1 billion. Through this acquisition, ArchiMed aims to strengthen and expand its product line while improving its customer base. This deal enables Natus to integrate ArchiMed's operational, medical, scientific, and financial expertise to expand internationally and grow its business. Natus Medical Incorporated is a US-based manufacturer of pediatric neurology devices, including neurostimulation devices.

Major companies operating in the pediatric neurology device market report are Johnson & Johnson Co, Abbott Laboratories, Medtronic PLC, Fujifilm Holdings Corporation, Siemens Healthineers AG, Koninklijke Philips NV, Stryker Corporation, GE HealthCare Technologies Inc., Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holding Inc., Terumo Corporation, Inova Health System, Masimo Corporation, KARL STORZ SE & Co. KG, Nihon Kohden Corporation, Integra LifeSciences Holdings Corp., Elekta AB, LivaNova PLC, Natus Medical Incorporated, Allengers Medical Systems Limited, Compumedics Limited, Cadwell Industries Inc., Spiegelberg GmbH & Co. KG, Elana Inc.

North America was the largest region in the pediatric neurology device market in 2023. The regions covered in the pediatric neurology device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric neurology device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pediatric neurology devices are medical instruments specifically designed to aid in the diagnosis, prevention, and treatment of various neurological disorders in children. These devices are utilized by pediatric neurologists and other medical professionals to address the complete spectrum of neurological disorders in pediatric patients.

The primary types of pediatric neurology devices include neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. Neurostimulation devices are medical equipment that alters the activity of the nervous system through electrical or magnetic stimulation. They are employed in the treatment of various conditions such as stroke, seizures, hydrocephalus, and oncology. The range of services and treatments associated with these devices includes electroencephalogram, intrathecal baclofen therapy, neurological evaluations, vagal nerve stimulation, among others. These devices are utilized by various end users, including hospitals, ambulatory surgery centers, and other healthcare facilities.

The pediatric neurology device market research report is one of a series of new reports that provides pediatric neurology device market statistics, including pediatric neurology device industry global market size, regional shares, competitors with a pediatric neurology device market share, detailed pediatric neurology device market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric neurology device industry. This pediatric neurology device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric neurology device market consists of sales of portable and wearable neurology devices, intracranial pressure (ICP) monitors, cerebral oximeters, and infusion pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.